248 related articles for article (PubMed ID: 37670965)
1. A Comprehensive Analysis of the Prognostic, Immunological and Diagnostic Role of CCNF in Pan-cancer.
Gao X; Bu H; Ge J; Gao X; Wang Y; Zhang Z; Wang L
J Cancer; 2023; 14(13):2431-2442. PubMed ID: 37670965
[No Abstract] [Full Text] [Related]
2. Integrated pan-cancer analysis and experimental verification of the roles of tropomyosin 4 in gastric cancer.
Guo Q; Zhao L; Yan N; Li Y; Guo C; Dang S; Shen X; Han J; Luo Y
Front Immunol; 2023; 14():1148056. PubMed ID: 36993958
[TBL] [Abstract][Full Text] [Related]
3. Pan-cancer Analysis of the Disulfidptosis-related Gene NCKAP1 and Its Prognostic Value for Lung Adenocarcinoma.
Zhu A; Zong Y; Wei S; Li Y; Fan Y; Liu S; Gao X
J Cancer; 2023; 14(17):3351-3367. PubMed ID: 37928421
[TBL] [Abstract][Full Text] [Related]
4. GLIPR2: a potential biomarker and therapeutic target unveiled - Insights from extensive pan-cancer analyses, with a spotlight on lung adenocarcinoma.
Lin W; Zhang S; Gu C; Zhu H; Liu Y
Front Immunol; 2024; 15():1280525. PubMed ID: 38476239
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance and Immunological Role of FBXO5 in Human Cancers: A Systematic Pan-Cancer Analysis.
Liu P; Wang X; Pan L; Han B; He Z
Front Immunol; 2022; 13():901784. PubMed ID: 35720327
[TBL] [Abstract][Full Text] [Related]
6. Pan-cancer analysis of the prognostic and immunological roles of
Liu S; Liu Y; Zhang X; Song X; Zhang B; Zhang Y
Front Genet; 2022; 13():1039440. PubMed ID: 36313454
[No Abstract] [Full Text] [Related]
7. Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma.
Zhu ZY; Tang N; Wang MF; Zhou JC; Wang JL; Ren HZ; Shi XL
Front Immunol; 2021; 12():781087. PubMed ID: 35069553
[TBL] [Abstract][Full Text] [Related]
8. GPC2 Is a Potential Diagnostic, Immunological, and Prognostic Biomarker in Pan-Cancer.
Chen G; Luo D; Zhong N; Li D; Zheng J; Liao H; Li Z; Lin X; Chen Q; Zhang C; Lu Y; Chan YT; Ren Q; Wang N; Feng Y
Front Immunol; 2022; 13():857308. PubMed ID: 35345673
[TBL] [Abstract][Full Text] [Related]
9. XRCC1: a potential prognostic and immunological biomarker in LGG based on systematic pan-cancer analysis.
Wang G; Li Y; Pan R; Yin X; Jia C; She Y; Huang L; Yang G; Chi H; Tian G
Aging (Albany NY); 2024 Jan; 16(1):872-910. PubMed ID: 38217545
[TBL] [Abstract][Full Text] [Related]
10. ERH Impacts Patient Prognosis and Tumor Immune Microenvironment: A Pan-Cancer Analysis.
Gong Q; Li Q; Shen X; Xu Z
Comb Chem High Throughput Screen; 2024 Apr; ():. PubMed ID: 38584561
[TBL] [Abstract][Full Text] [Related]
11. A pan-cancer analysis of the oncogenic role of ribonucleotide reductase subunit M2 in human tumors.
Li Y; Fu W; Geng Z; Song Y; Yang X; He T; Wu J; Wang B
PeerJ; 2022; 10():e14432. PubMed ID: 36518297
[TBL] [Abstract][Full Text] [Related]
12. Pan-cancer analysis reveals correlation between RAB3B expression and tumor heterogeneity, immune microenvironment, and prognosis in multiple cancers.
Liu XS; Chen YL; Chen YX; Wu RM; Tan F; Wang YL; Liu ZY; Gao Y; Pei ZJ
Sci Rep; 2024 Apr; 14(1):9881. PubMed ID: 38688977
[TBL] [Abstract][Full Text] [Related]
13. ORC6, a novel prognostic biomarker, correlates with T regulatory cell infiltration in prostate adenocarcinoma: a pan-cancer analysis.
Lin Y; Zhang Y; Tuo Z; Gao L; Ding D; Bi L; Yu D; Lv Z; Wang J; Chen X
BMC Cancer; 2023 Mar; 23(1):285. PubMed ID: 36978046
[TBL] [Abstract][Full Text] [Related]
14. Pan-cancer analysis reveals potential of FAM110A as a prognostic and immunological biomarker in human cancer.
Zhong H; Shi Q; Wen Q; Chen J; Li X; Ruan R; Zeng S; Dai X; Xiong J; Li L; Lei W; Deng J
Front Immunol; 2023; 14():1058627. PubMed ID: 36923407
[TBL] [Abstract][Full Text] [Related]
15. Cyclin B1: A potential prognostic and immunological biomarker in pan-cancer.
Chen Q; Ouyang L; Liu Q
Biomol Biomed; 2024 Apr; ():. PubMed ID: 38581717
[TBL] [Abstract][Full Text] [Related]
16. ARPC2: A Pan-Cancer Prognostic and Immunological Biomarker That Promotes Hepatocellular Carcinoma Cell Proliferation and Invasion.
Huang S; Dong C; Li D; Xu Y; Wu J
Front Cell Dev Biol; 2022; 10():896080. PubMed ID: 35733852
[No Abstract] [Full Text] [Related]
17. ANXA2 is a potential biomarker for cancer prognosis and immune infiltration: A systematic pan-cancer analysis.
Ning Y; Li Y; Wang H
Front Genet; 2023; 14():1108167. PubMed ID: 36713082
[No Abstract] [Full Text] [Related]
18. Increased expression of Cyclin F in liver cancer predicts poor prognosis: A study based on TCGA database.
Zelong Y; Han Y; Ting G; Yifei W; Kun H; Haoran H; Yong C
Medicine (Baltimore); 2021 Aug; 100(31):e26623. PubMed ID: 34397798
[TBL] [Abstract][Full Text] [Related]
19. A pan-cancer characterization of immune-related NFIL3 identifies potential predictive biomarker.
Fei Q; Zhang X; Wang S; Shu G; Yin G
J Cancer; 2024; 15(5):1271-1286. PubMed ID: 38356719
[No Abstract] [Full Text] [Related]
20. Tubulin alpha-1b chain was identified as a prognosis and immune biomarker in pan-cancer combing with experimental validation in breast cancer.
Wang Y; Li Y; Jing Y; Yang Y; Wang H; Ismtula D; Guo C
Sci Rep; 2024 Apr; 14(1):8201. PubMed ID: 38589634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
